Literature DB >> 18297417

Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

Angelo B Cunha1, Ana C Andreazza, Fabiano A Gomes, Benicio N Frey, Leonardo E da Silveira, Carlos A Gonçalves, Flávio Kapczinski.   

Abstract

There has been an increasing interest in the role of the immune and inflammatory systems in mood disorders. Mood episodes are associated with changes in acute phase proteins such as high-sensitivity C-reactive protein (hsCRP). The present study investigated serum hsCRP in manic, depressed, and euthymic BD patients as compared to matched healthy controls. Serum hsCRP was assessed using an ultrasensitive assay of particle-enhanced immunoturbidimetric latex agglutination. Serum hsCRP levels were increased in manic BD patients, as compared to euthymic, depressed patients and healthy controls (P < 0.001). These findings add to the notion that changes in the inflammatory system take place during acute episodes of mania.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297417     DOI: 10.1007/s00406-007-0797-0

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  42 in total

Review 1.  Functional impairment and cognition in bipolar disorder.

Authors:  C A Zarate; M Tohen; M Land; S Cavanagh
Journal:  Psychiatr Q       Date:  2000

2.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

3.  Antidepressant therapy and C-reactive protein levels.

Authors:  Sinead M O'Brien; Lucinda V Scott; Timothy G Dinan
Journal:  Br J Psychiatry       Date:  2006-05       Impact factor: 9.319

4.  High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania.

Authors:  Tiao-Lai Huang; Fu-Chen Lin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-10-24       Impact factor: 5.067

5.  Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

Authors:  Yong-Ku Kim; Hyun-Gang Jung; Aye-Mu Myint; Hyun Kim; Sun-Hwa Park
Journal:  J Affect Disord       Date:  2007-04-16       Impact factor: 4.839

6.  Serum C-reactive protein elevation predicts poor clinical outcome in patients with distal type acute aortic dissection: association with the occurrence of oxygenation impairment.

Authors:  Yasuo Sugano; Toshihisa Anzai; Tsutomu Yoshikawa; Toru Satoh; Shiro Iwanaga; Takeharu Hayashi; Yuichiro Maekawa; Hideyuki Shimizu; Ryohei Yozu; Satoshi Ogawa
Journal:  Int J Cardiol       Date:  2005-06-22       Impact factor: 4.164

7.  Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report.

Authors:  Benício N Frey; Ana C Andreazza; Maurício Kunz; Fabiano A Gomes; João Quevedo; Mirian Salvador; Carlos Alberto Gonçalves; Flávio Kapczinski
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-07-20       Impact factor: 5.067

8.  Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder.

Authors:  Adriane R Rosa; Benício N Frey; Ana C Andreazza; Keila M Ceresér; Angelo B M Cunha; João Quevedo; Aida Santin; Carmem Gottfried; Carlos A Gonçalves; Eduard Vieta; Flávio Kapczinski
Journal:  Neurosci Lett       Date:  2006-09-07       Impact factor: 3.046

9.  Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder.

Authors:  Cengiz Tuglu; S Hakan Kara; Okan Caliyurt; Erdal Vardar; Ercan Abay
Journal:  Psychopharmacology (Berl)       Date:  2003-08-30       Impact factor: 4.530

Review 10.  S100B in neuropathologic states: the CRP of the brain?

Authors:  Jon Sen; Antonio Belli
Journal:  J Neurosci Res       Date:  2007-05-15       Impact factor: 4.164

View more
  26 in total

Review 1.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

4.  Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Barreto Huguet; Vanessa Amaral Mendonça; Lirlândia Pires Sousa; Fernando Silva Neves; Moisés Evandro Bauer; Antônio Lúcio Teixeira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-05-06       Impact factor: 5.270

Review 5.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

6.  Effect of Increased Neutrophil-to-Lymphocyte Ratio (NLR) and Decreased Mean Platelet Volume (MPV) Values on Inflammation in Acute Mania.

Authors:  Hasan Mayda; Ahmet Ahsen; Erman Bağcioğlu; Ahmet Öztürk; Bülent Bahçeci; Etem Soyuçok; Erol Başpinar; Memnune Sena Ulu
Journal:  Noro Psikiyatr Ars       Date:  2016-12-01       Impact factor: 1.339

Review 7.  Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy.

Authors:  Shakuntla Gondalia; Lisa Parkinson; Con Stough; Andrew Scholey
Journal:  Psychopharmacology (Berl)       Date:  2019-04-30       Impact factor: 4.530

Review 8.  Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications.

Authors:  Nora Hamdani; Raphael Doukhan; Ozlem Kurtlucan; Ryad Tamouza; Marion Leboyer
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

Review 9.  Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.

Authors:  Cynthia V Calkin
Journal:  Ann Med       Date:  2019-08-27       Impact factor: 4.709

10.  Peripheral inflammation during abnormal mood states in bipolar I disorder.

Authors:  Jess G Fiedorowicz; Alan R Prossin; Casey P Johnson; Gary E Christensen; Vincent A Magnotta; John A Wemmie
Journal:  J Affect Disord       Date:  2015-08-21       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.